Intraoral Mitochondrial-Targeted Gs Nitroxide JP4-039 Ameliorates Radiation-Induced Mucositis and Gene Transcript Biomarkers in Head and Neck Tumor-Bearing Fanconi Anemia (FA) (FANCD2-/-) Mice

Michael Epperly,Ashwin Shinde,Byung Han Rhieu,Hebist Berhane,Eva Guinan,Kalindi Parmar,Hong Wang,Darcy Franicola,Xichen Zhang,Tracy Dixon,Joel Greenberger

DOI: https://doi.org/10.1016/j.exphem.2014.07.114

IF: 3.249

2014-01-01

Experimental Hematology

Abstract:BackgroundTheir DNA damage response defect sensitizes Fanconi Anemia (FA) patients to irradiation. We evaluated the effect of intraoral mitochondrial-targeted antioxidant, JP4-039, in a novel F15 emulsion, on irradiation induced mucositis in fractionated irradiated FA mice with orthotopic tumorsMethodsTC-1 squamous cell carcinoma cells (1 x 106) were injected into the left cheek of Fancd2+/+,Fancd2+/-, and Fancd2-/-;mice (C57BL/6). Once the tumors were palpable, mice were treated with fractionated irradiation of 8 Gy x 4 days to the oral cavity. Subgroups of mice (N=4/group) received intraoral JP4-039/F15 (100 ul containing 4 mg/ml of JP4-039) 10 minutes prior to irradiation, F15 alone or irradiation alone. Tumor volume, gene transcripts by real time polymerase chain reaction (RT-PCR), and histology were measuredResultsFancd2-/- mice showed elevated baseline transcripts for MnSOD, Nrf2, and p21 (all p<0.0009) and suppressed transcripts for NFKB, TGF-B, IL1a, and Gadd45 (all p<0.0020) compared to FancD2+/+ mice. Tumor bearing Fancd2-/- mice had reduction of NFKB, MnSOD, p21, and IL1a transcripts, while tumor bearing Fancd2+/+ and Fancd2+/- mice showed elevated transcript for TGFB, Nrf2, Gadd45, IL1a, and p-21 (0.0412 and 0.0041, respectively). Irradiation altered gene transcripts in the tumors and normal tissue were more profound in Fancd2-/- mice. Intraoral JP4-039/F15 reduced irradiation-induced mucosal ulceration in all mouse groups, prevented RNA transcript changes, but did not alter tumor controlConclusionsThe Fancd2-/- mouse is a valuable model for elucidating the mechanism of mitochondrial targeted radioprotector drugs in patients with defects in the DNA damage response pathway. Supported by NIAID/NIH U19-A1068021 and the Fanconi Anemia Research Foundation. BackgroundTheir DNA damage response defect sensitizes Fanconi Anemia (FA) patients to irradiation. We evaluated the effect of intraoral mitochondrial-targeted antioxidant, JP4-039, in a novel F15 emulsion, on irradiation induced mucositis in fractionated irradiated FA mice with orthotopic tumors Their DNA damage response defect sensitizes Fanconi Anemia (FA) patients to irradiation. We evaluated the effect of intraoral mitochondrial-targeted antioxidant, JP4-039, in a novel F15 emulsion, on irradiation induced mucositis in fractionated irradiated FA mice with orthotopic tumors MethodsTC-1 squamous cell carcinoma cells (1 x 106) were injected into the left cheek of Fancd2+/+,Fancd2+/-, and Fancd2-/-;mice (C57BL/6). Once the tumors were palpable, mice were treated with fractionated irradiation of 8 Gy x 4 days to the oral cavity. Subgroups of mice (N=4/group) received intraoral JP4-039/F15 (100 ul containing 4 mg/ml of JP4-039) 10 minutes prior to irradiation, F15 alone or irradiation alone. Tumor volume, gene transcripts by real time polymerase chain reaction (RT-PCR), and histology were measured TC-1 squamous cell carcinoma cells (1 x 106) were injected into the left cheek of Fancd2+/+,Fancd2+/-, and Fancd2-/-;mice (C57BL/6). Once the tumors were palpable, mice were treated with fractionated irradiation of 8 Gy x 4 days to the oral cavity. Subgroups of mice (N=4/group) received intraoral JP4-039/F15 (100 ul containing 4 mg/ml of JP4-039) 10 minutes prior to irradiation, F15 alone or irradiation alone. Tumor volume, gene transcripts by real time polymerase chain reaction (RT-PCR), and histology were measured ResultsFancd2-/- mice showed elevated baseline transcripts for MnSOD, Nrf2, and p21 (all p<0.0009) and suppressed transcripts for NFKB, TGF-B, IL1a, and Gadd45 (all p<0.0020) compared to FancD2+/+ mice. Tumor bearing Fancd2-/- mice had reduction of NFKB, MnSOD, p21, and IL1a transcripts, while tumor bearing Fancd2+/+ and Fancd2+/- mice showed elevated transcript for TGFB, Nrf2, Gadd45, IL1a, and p-21 (0.0412 and 0.0041, respectively). Irradiation altered gene transcripts in the tumors and normal tissue were more profound in Fancd2-/- mice. Intraoral JP4-039/F15 reduced irradiation-induced mucosal ulceration in all mouse groups, prevented RNA transcript changes, but did not alter tumor control Fancd2-/- mice showed elevated baseline transcripts for MnSOD, Nrf2, and p21 (all p<0.0009) and suppressed transcripts for NFKB, TGF-B, IL1a, and Gadd45 (all p<0.0020) compared to FancD2+/+ mice. Tumor bearing Fancd2-/- mice had reduction of NFKB, MnSOD, p21, and IL1a transcripts, while tumor bearing Fancd2+/+ and Fancd2+/- mice showed elevated transcript for TGFB, Nrf2, Gadd45, IL1a, and p-21 (0.0412 and 0.0041, respectively). Irradiation altered gene transcripts in the tumors and normal tissue were more profound in Fancd2-/- mice. Intraoral JP4-039/F15 reduced irradiation-induced mucosal ulceration in all mouse groups, prevented RNA transcript changes, but did not alter tumor control ConclusionsThe Fancd2-/- mouse is a valuable model for elucidating the mechanism of mitochondrial targeted radioprotector drugs in patients with defects in the DNA damage response pathway. Supported by NIAID/NIH U19-A1068021 and the Fanconi Anemia Research Foundation. The Fancd2-/- mouse is a valuable model for elucidating the mechanism of mitochondrial targeted radioprotector drugs in patients with defects in the DNA damage response pathway. Supported by NIAID/NIH U19-A1068021 and the Fanconi Anemia Research Foundation.